Hsbc Holdings PLC Has $6.83 Million Stake in National Health Investors, Inc. $NHI

Hsbc Holdings PLC boosted its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 12.1% in the 1st quarter, Holdings Channel.com reports. The firm owned 84,520 shares of the real estate investment trust’s stock after purchasing an additional 9,094 shares during the quarter. Hsbc Holdings PLC’s holdings in National Health Investors were worth $6,834,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in NHI. Renaissance Group LLC lifted its holdings in shares of National Health Investors by 3.8% during the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after buying an additional 117 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 136 shares during the last quarter. Captrust Financial Advisors grew its stake in shares of National Health Investors by 1.7% in the fourth quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock worth $680,000 after acquiring an additional 146 shares during the last quarter. Inspire Investing LLC increased its position in National Health Investors by 3.2% during the first quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust’s stock worth $510,000 after acquiring an additional 198 shares during the period. Finally, Mackenzie Financial Corp increased its position in National Health Investors by 6.7% during the third quarter. Mackenzie Financial Corp now owns 3,201 shares of the real estate investment trust’s stock worth $254,000 after acquiring an additional 200 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

Insider Activity at National Health Investors

In other National Health Investors news, CEO D. Eric Mendelsohn bought 1,500 shares of the stock in a transaction dated Friday, June 5th. The stock was bought at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This represents a 1.14% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the acquisition, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently issued reports on NHI shares. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a report on Wednesday, April 22nd. Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. BMO Capital Markets cut their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Truist Financial reduced their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Finally, Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Stock Up 0.1%

Shares of NYSE NHI opened at $80.05 on Friday. National Health Investors, Inc. has a 52-week low of $67.94 and a 52-week high of $91.38. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The business has a fifty day moving average of $74.90 and a two-hundred day moving average of $79.71. The stock has a market cap of $3.88 billion, a PE ratio of 25.82, a PEG ratio of 3.59 and a beta of 0.51.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.6%. National Health Investors’s payout ratio is 118.71%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.